|
PRDM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66293670342566E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63535851527286E-12 |
| Normal-vs-Stage2 |
1.43489997661561E-10 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.492400E-01 |
| Stage1-vs-Stage3 |
1.806650E-01 |
| Stage1-vs-Stage4 |
2.111500E-02 |
| Stage2-vs-Stage3 |
4.805600E-02 |
| Stage2-vs-Stage4 |
1.063800E-02 |
| Stage3-vs-Stage4 |
3.898200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62647673107585E-12 |
| Normal-vs-AfricanAmerican |
7.27380000009603E-07 |
| Normal-vs-Asian |
7.105427357601E-15 |
| Caucasian-vs-AfricanAmerican |
8.485600E-02 |
| Caucasian-vs-Asian |
8.172000E-01 |
| AfricanAmerican-vs-Asian |
8.170000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
1.63669078290241E-12 |
| Male-vs-Female |
1.117830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44089209850063E-15 |
| Normal-vs-Age(41-60Yrs) |
1.63280500231622E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63025148935958E-12 |
| Normal-vs-Age(81-100Yrs) |
8.34090000000343E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.981600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.178400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.858400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.552400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.497000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.207000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.54230000000344E-05 |
| Classical-VS-Follicular |
4.064000E-01 |
| Classical-VS-Other |
2.354400E-01 |
| Classical-VS-Normal |
1.71018754713259E-12 |
| Tall-VS-Follicular |
2.045900E-04 |
| Tall-VS-Other |
8.304800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.065000E-01 |
| Follicular-VS-Normal |
1.68998148808441E-12 |
| Other-VS-Normal |
1.83439999967838E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63635771599502E-12 |
| Normal-vs-N1 |
1.55431223447522E-14 |
| N0-vs-N1 |
2.290400E-01 |
|
|
